| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -48% |
| 3Y CAGR | -82% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +311% |
| 3Y CAGR | -25% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,364.60 +28.20 (1.21%) | 17,953.96 | 26.48 | 5.33 | ||
PfizerPFIZER | ₹3,821.60 +182.90 (5.03%) | 17,370.41 | 23.63 | 4.13 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,345.00 +53.50 (0.85%) | 15,851.50 | 93.45 | 18.16 | ||
Natco PharmaNATCOPHARM | ₹781.60 -4.15 (0.53%) | 15,334.45 | 13.4 | 1.46 |